Edition:
India

People: Pacira Biosciences Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

40.35USD
9:55pm IST
Change (% chg)

$-0.13 (-0.32%)
Prev Close
$40.48
Open
$40.35
Day's High
$40.43
Day's Low
$39.77
Volume
33,529
Avg. Vol
163,009
52-wk High
$54.92
52-wk Low
$35.09

Reinhart, Charles 

Mr. Charles A. Reinhart, III., is Chief Financial Officer of the Company. Prior to joining Pacira, he was the Chief Financial Officer at Covis Pharmaceuticals, Inc., a specialty pharmaceutical company, from September 2014 to October 2015. From September 2011 to August 2014, he served as Executive Vice President and Chief Financial Officer of Archimedes Pharma Ltd., a specialty pharmaceutical company. Mr. Reinhart also served as Senior Vice President and Chief Financial Officer of PharmAthene, Inc., a biodefense company engaged in the development of next generation medical countermeasures against biological and chemical threats, from 2009 to 2011. In addition, Mr. Reinhart has previously held senior financial roles at Millennium Pharmaceuticals, Inc., Cephalon, Inc. and several early-stage life sciences companies. Mr. Reinhart earned his Bachelor of Science degree from Lehigh University and his MBA from the Wharton School of the University of Pennsylvania. He is also a CPA.

Basic Compensation

Total Annual Compensation, USD 640,827
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 766,846
Fiscal Year Total, USD 1,407,670

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --